73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Trends in genitourinary cancers examined in the United States

Trends in genitourinary cancers examined in the United States

by Elana GotkineThe highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a st

Trends in genitourinary cancers examined in the United States

by Elana GotkineThe highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a st
Scientists aim to understand why men with prostate cancer are at higher risk of Alzheimer's

Scientists aim to understand why men with prostate cancer are at higher risk of Alzheimer's

byMedical College of Georgia at Augusta UniversityDr. Qin Wang and Augusta University graduate student Mae Aida. Credit: Michael Holahan, Augusta UniversityResearchers at the Medical College of

Scientists aim to understand why men with prostate cancer are at higher risk of Alzheimer's

byMedical College of Georgia at Augusta UniversityDr. Qin Wang and Augusta University graduate student Mae Aida. Credit: Michael Holahan, Augusta UniversityResearchers at the Medical College of
Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same
New combination blood test for pancreatic cancer may catch disease earlier

New combination blood test for pancreatic cancer may catch disease earlier

by Van Andel Research InstituteDr. Brian Haab. Credit: Van Andel Research InstituteA new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before

New combination blood test for pancreatic cancer may catch disease earlier

by Van Andel Research InstituteDr. Brian Haab. Credit: Van Andel Research InstituteA new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before
Researchers unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

Researchers unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

byInstitute for Research in Biomedicine (IRB Barcelona)The origin of second solid tumors of cases 3 (A–D) and 4 (E–F). A, Eight years after the development of NB, the child presented with MRT. B

Researchers unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

byInstitute for Research in Biomedicine (IRB Barcelona)The origin of second solid tumors of cases 3 (A–D) and 4 (E–F). A, Eight years after the development of NB, the child presented with MRT. B
Study demonstrates antitumor action of substance present in Brazilian green propolis

Study demonstrates antitumor action of substance present in Brazilian green propolis

FEBRUARY 7, 2024byFAPESPLDH assay representing the percentage of membrane integrity damage obtained for fibroblast (A) and glioblastoma (B) cell lines, after 24 h incubation, exposed to 0, 1, 10

Study demonstrates antitumor action of substance present in Brazilian green propolis

FEBRUARY 7, 2024byFAPESPLDH assay representing the percentage of membrane integrity damage obtained for fibroblast (A) and glioblastoma (B) cell lines, after 24 h incubation, exposed to 0, 1, 10
2023 cisplatin shortage tied to use of alternatives for head, neck cancer

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente
How colliding genetic processes drive aggressive cancers

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch
RNA splicing strategy corrects tumor suppressor gene in neuroendocrine cancers

RNA splicing strategy corrects tumor suppressor gene in neuroendocrine cancers

byOsaka UniversityGraphical abstracts. REST_SSO directly modifies REST splicing and RE1 gene expression, whereas both REST_SSO and SRRM4_ASO exhibit antitumor effects in SCLC/NEPCa. Credit: 2024

RNA splicing strategy corrects tumor suppressor gene in neuroendocrine cancers

byOsaka UniversityGraphical abstracts. REST_SSO directly modifies REST splicing and RE1 gene expression, whereas both REST_SSO and SRRM4_ASO exhibit antitumor effects in SCLC/NEPCa. Credit: 2024
Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l
Repurposing heart drugs to target cancer cells

Repurposing heart drugs to target cancer cells

by MRC London Institute of Medical SciencesCredit: CC0 Public DomainSenescence is a cellular stress response that results in the stable growth arrest of old and damaged cells. The past decade has reve

Repurposing heart drugs to target cancer cells

by MRC London Institute of Medical SciencesCredit: CC0 Public DomainSenescence is a cellular stress response that results in the stable growth arrest of old and damaged cells. The past decade has reve
Expert panel updates cancer and aging guidelines

Expert panel updates cancer and aging guidelines

byCity of Hope National Medical CenterWilliam Dale, M.D., Ph.D., City of Hope’s George Tsai Family Chair in Geriatric Oncology in Honor of Arti Hurria, M.D., says, "The geriatric assessment

Expert panel updates cancer and aging guidelines

byCity of Hope National Medical CenterWilliam Dale, M.D., Ph.D., City of Hope’s George Tsai Family Chair in Geriatric Oncology in Honor of Arti Hurria, M.D., says, "The geriatric assessment